BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18628228)

  • 1. Diffuse ground-glass opacities in a patient with Hodgkin lymphoma and progressive respiratory failure.
    Godoy MC; Nonaka D; Raphael BG; Vlahos I
    Chest; 2008 Jul; 134(1):207-12. PubMed ID: 18628228
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of bleomycin-induced lung toxicity.
    Tetikkurt C; Ongel D; Tetikkurt S
    Monaldi Arch Chest Dis; 2018 Nov; 88(3):981. PubMed ID: 30398042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin-induced "flagellate dermatitis".
    Arseculeratne G; Berroeta L; Meiklejohn D; Mountain RE; Ryan JC; Spinou C; Das SN; Evans AT; Lowe JG
    Arch Dermatol; 2007 Nov; 143(11):1461-2. PubMed ID: 18025386
    [No Abstract]   [Full Text] [Related]  

  • 4. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
    Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
    Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial pneumonitis associated with bleomycin therapy.
    Luna MA; Bedrossian CW; Lichtiger B; Salem PA
    Am J Clin Pathol; 1972 Nov; 58(5):501-10. PubMed ID: 4118423
    [No Abstract]   [Full Text] [Related]  

  • 6. Streaked discoloration on the upper body.
    Chapman SE; Lenz BL; Bandino JP
    Cutis; 2019 Sep; 104(3):E34-E36. PubMed ID: 31675411
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fatal bleomycin induced pneumomediastinum and bilateral pneumothorax].
    Jennane S; Haidouri S; Zine Filali K; Ahchouch S; Mahtat EM; Doghmi K; Mikdame M
    Rev Pneumol Clin; 2017 Jun; 73(3):153-156. PubMed ID: 28365047
    [No Abstract]   [Full Text] [Related]  

  • 8. Bleomycin-induced flagellate erythema in a patient with Hodgkin's lymphoma - A case report and review of literature.
    Vennepureddy A; Siddique MN; Odaimi M; Terjanian T
    J Oncol Pharm Pract; 2016 Jun; 22(3):556-60. PubMed ID: 25855241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-1974.
    N Engl J Med; 1974 Feb; 290(7):390-6. PubMed ID: 4129576
    [No Abstract]   [Full Text] [Related]  

  • 10. Bleomycin induced flagellate erythema: Revisiting a unique complication.
    Biswas A; Chaudhari PB; Sharma P; Singh L; Julka PK; Sethuraman G
    J Cancer Res Ther; 2013; 9(3):500-3. PubMed ID: 24125992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG positron emission tomography/computerized tomography features of bleomycin-induced pneumonitis.
    Kirsch J; Arrossi AV; Yoon JK; Wu G; Neumann DR
    J Thorac Imaging; 2006 Aug; 21(3):228-30. PubMed ID: 16915070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pruritic rash in a patient with Hodgkin lymphoma. Bleomycin-induced flagellate dermatosis.
    Simpson RC; Da Forno P; Nagarajan C; Harman KE
    Clin Exp Dermatol; 2011 Aug; 36(6):680-2. PubMed ID: 21771014
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac surgery after bleomycin therapy.
    Mascio CE; Ross AF; Niles SD; Richenbacher WE
    Am Surg; 2009 Jun; 75(6):514-5. PubMed ID: 19545102
    [No Abstract]   [Full Text] [Related]  

  • 14. Bleomycin: pulmonary toxicity.
    Rudders RA
    Ann Intern Med; 1973 Apr; 78(4):618. PubMed ID: 4121001
    [No Abstract]   [Full Text] [Related]  

  • 15. Bleomycin: a clinical evaluation of the agent on its own or in combination with mitomycin C.
    van Dyk JJ; Falkson G; Falkson HC
    S Afr Med J; 1972 Dec; 46(49):1921-6. PubMed ID: 4120162
    [No Abstract]   [Full Text] [Related]  

  • 16. Revisiting bleomycin from pathophysiology to safe clinical use.
    Froudarakis M; Hatzimichael E; Kyriazopoulou L; Lagos K; Pappas P; Tzakos AG; Karavasilis V; Daliani D; Papandreou C; Briasoulis E
    Crit Rev Oncol Hematol; 2013 Jul; 87(1):90-100. PubMed ID: 23312772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin's disease.
    Real E; Roca MJ; Viñuales A; Pastor E; Grau E
    Haematologica; 1999 Jul; 84(7):667-8. PubMed ID: 10406918
    [No Abstract]   [Full Text] [Related]  

  • 18. Bleomycin in the reticuloses.
    European Organization for Research on the Treatment of Cancer, Co-Operative Group for Leukaemia and Reticulocytoses
    Br Med J; 1972 Jan; 1(5795):285-6. PubMed ID: 4109401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early clinical experience with bleomycin in the United Kingdom in series of 105 patients.
    Halnan KE; Bleehen NM; Brewin TB; Deeley TJ; Harrison DF; Howland C; Kunkler PB; Ritchie GL; Wiltshaw E; Todd ID
    Br Med J; 1972 Dec; 4(5841):635-8. PubMed ID: 4118975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary toxicity caused by drugs].
    Carrión Valero F; Marín Pardo J
    Arch Bronconeumol; 1999 Dec; 35(11):550-9. PubMed ID: 10687040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.